CN110226741A - 一种溃疡性结肠炎专用型临床营养配方及其制备方法 - Google Patents
一种溃疡性结肠炎专用型临床营养配方及其制备方法 Download PDFInfo
- Publication number
- CN110226741A CN110226741A CN201910539305.2A CN201910539305A CN110226741A CN 110226741 A CN110226741 A CN 110226741A CN 201910539305 A CN201910539305 A CN 201910539305A CN 110226741 A CN110226741 A CN 110226741A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- powder
- ulcerative colitis
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010009900 Colitis ulcerative Diseases 0.000 title claims abstract description 43
- 201000006704 Ulcerative Colitis Diseases 0.000 title claims abstract description 42
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 36
- 230000035764 nutrition Effects 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000009472 formulation Methods 0.000 title description 20
- 239000000463 material Substances 0.000 claims abstract description 27
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000011575 calcium Substances 0.000 claims abstract description 16
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 16
- 235000001465 calcium Nutrition 0.000 claims abstract description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 15
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 15
- 230000035622 drinking Effects 0.000 claims abstract description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000008216 herbs Nutrition 0.000 claims abstract description 14
- 230000010354 integration Effects 0.000 claims abstract description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 239000011701 zinc Substances 0.000 claims abstract description 11
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 11
- 235000016804 zinc Nutrition 0.000 claims abstract description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 10
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 10
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 10
- 239000011710 vitamin D Substances 0.000 claims abstract description 10
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 10
- 229940046008 vitamin d Drugs 0.000 claims abstract description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960000304 folic acid Drugs 0.000 claims abstract description 9
- 235000019152 folic acid Nutrition 0.000 claims abstract description 9
- 239000011724 folic acid Substances 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- 239000011777 magnesium Substances 0.000 claims abstract description 8
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 8
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004615 ingredient Substances 0.000 claims abstract description 7
- 229910052742 iron Inorganic materials 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 6
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 5
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 5
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 5
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 5
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 5
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 5
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 5
- 239000011719 vitamin A Substances 0.000 claims abstract description 5
- 229940045997 vitamin a Drugs 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 53
- 229960005069 calcium Drugs 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 239000003094 microcapsule Substances 0.000 claims description 14
- 229940088594 vitamin Drugs 0.000 claims description 12
- 239000011782 vitamin Substances 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 11
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- 235000019197 fats Nutrition 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 235000013325 dietary fiber Nutrition 0.000 claims description 7
- 229940091250 magnesium supplement Drugs 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 229940042585 tocopherol acetate Drugs 0.000 claims description 7
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 6
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 6
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 235000021323 fish oil Nutrition 0.000 claims description 6
- 230000003301 hydrolyzing effect Effects 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- 244000099147 Ananas comosus Species 0.000 claims description 5
- 235000007119 Ananas comosus Nutrition 0.000 claims description 5
- 240000006432 Carica papaya Species 0.000 claims description 5
- 235000009467 Carica papaya Nutrition 0.000 claims description 5
- 229930182816 L-glutamine Natural products 0.000 claims description 5
- 102000015636 Oligopeptides Human genes 0.000 claims description 5
- 108010038807 Oligopeptides Proteins 0.000 claims description 5
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- 235000014633 carbohydrates Nutrition 0.000 claims description 5
- 239000011666 cyanocobalamin Substances 0.000 claims description 5
- 229960002104 cyanocobalamin Drugs 0.000 claims description 5
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 5
- 239000004222 ferrous gluconate Substances 0.000 claims description 5
- 235000013924 ferrous gluconate Nutrition 0.000 claims description 5
- 229960001645 ferrous gluconate Drugs 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 235000013311 vegetables Nutrition 0.000 claims description 5
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 5
- 235000005282 vitamin D3 Nutrition 0.000 claims description 5
- 239000011647 vitamin D3 Substances 0.000 claims description 5
- 229940021056 vitamin d3 Drugs 0.000 claims description 5
- 239000011670 zinc gluconate Substances 0.000 claims description 5
- 235000011478 zinc gluconate Nutrition 0.000 claims description 5
- 229960000306 zinc gluconate Drugs 0.000 claims description 5
- 235000003130 Arctium lappa Nutrition 0.000 claims description 4
- 235000008078 Arctium minus Nutrition 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000001755 magnesium gluconate Substances 0.000 claims description 4
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 4
- 229960003035 magnesium gluconate Drugs 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 229960003390 magnesium sulfate Drugs 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 4
- 235000019192 riboflavin Nutrition 0.000 claims description 4
- 239000002151 riboflavin Substances 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 229960000984 tocofersolan Drugs 0.000 claims description 4
- QWWVBNODQCWBAZ-WHFBIAKZSA-N (2r)-2-amino-3-[(2r)-2-carboxy-2-(methylamino)ethyl]sulfanylpropanoic acid Chemical compound CN[C@H](C(O)=O)CSC[C@H](N)C(O)=O QWWVBNODQCWBAZ-WHFBIAKZSA-N 0.000 claims description 3
- 240000005528 Arctium lappa Species 0.000 claims description 3
- 235000006264 Asimina triloba Nutrition 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims description 3
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 3
- 102000007544 Whey Proteins Human genes 0.000 claims description 3
- 108010046377 Whey Proteins Proteins 0.000 claims description 3
- 229960002061 ergocalciferol Drugs 0.000 claims description 3
- 229960000342 retinol acetate Drugs 0.000 claims description 3
- 239000011770 retinyl acetate Substances 0.000 claims description 3
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 3
- 235000019173 retinyl acetate Nutrition 0.000 claims description 3
- 235000001892 vitamin D2 Nutrition 0.000 claims description 3
- 239000011653 vitamin D2 Substances 0.000 claims description 3
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 3
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 claims description 2
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 241000234435 Lilium Species 0.000 claims description 2
- 240000003183 Manihot esculenta Species 0.000 claims description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 2
- 244000197580 Poria cocos Species 0.000 claims description 2
- 235000008599 Poria cocos Nutrition 0.000 claims description 2
- 229920000294 Resistant starch Polymers 0.000 claims description 2
- 240000007651 Rubus glaucus Species 0.000 claims description 2
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 2
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 2
- 239000001354 calcium citrate Substances 0.000 claims description 2
- 229960004256 calcium citrate Drugs 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
- 235000011010 calcium phosphates Nutrition 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- 239000010495 camellia oil Substances 0.000 claims description 2
- 210000003022 colostrum Anatomy 0.000 claims description 2
- 235000021277 colostrum Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 2
- 235000021254 resistant starch Nutrition 0.000 claims description 2
- 239000011435 rock Substances 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 239000011746 zinc citrate Substances 0.000 claims description 2
- 235000006076 zinc citrate Nutrition 0.000 claims description 2
- 229940068475 zinc citrate Drugs 0.000 claims description 2
- 239000011787 zinc oxide Substances 0.000 claims description 2
- 229960001296 zinc oxide Drugs 0.000 claims description 2
- 235000014692 zinc oxide Nutrition 0.000 claims description 2
- 235000021241 α-lactalbumin Nutrition 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- 235000004835 α-tocopherol Nutrition 0.000 claims description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 102000008857 Ferritin Human genes 0.000 claims 1
- 108050000784 Ferritin Proteins 0.000 claims 1
- 238000008416 Ferritin Methods 0.000 claims 1
- 229920001100 Polydextrose Polymers 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 235000019504 cigarettes Nutrition 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 235000019700 dicalcium phosphate Nutrition 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 235000013856 polydextrose Nutrition 0.000 claims 1
- 239000001259 polydextrose Substances 0.000 claims 1
- 229940035035 polydextrose Drugs 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- 235000008939 whole milk Nutrition 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 abstract description 28
- 206010061218 Inflammation Diseases 0.000 abstract description 7
- 230000004054 inflammatory process Effects 0.000 abstract description 7
- 230000000968 intestinal effect Effects 0.000 abstract description 7
- 230000001228 trophic effect Effects 0.000 abstract description 3
- 239000011691 vitamin B1 Substances 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 201000010099 disease Diseases 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 description 10
- 235000010755 mineral Nutrition 0.000 description 10
- 239000011707 mineral Substances 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000011231 Crohn disease Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 206010009887 colitis Diseases 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- -1 oligofructose Chemical compound 0.000 description 4
- 238000004393 prognosis Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 239000002893 slag Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010025476 Malabsorption Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010041969 Steatorrhoea Diseases 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000003243 intestinal obstruction Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 208000001162 steatorrhea Diseases 0.000 description 2
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 244000294263 Arctium minus Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- BNBQLHFMDIMQCX-UHFFFAOYSA-N Cc1ncc(COP(O)(O)=O)c(C=O)c1O.Cc1ncc(COP(O)(O)=O)c(C=O)c1O Chemical compound Cc1ncc(COP(O)(O)=O)c(C=O)c1O.Cc1ncc(COP(O)(O)=O)c(C=O)c1O BNBQLHFMDIMQCX-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 240000000387 Hydrophyllum virginianum Species 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 208000027182 Ileal disease Diseases 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 208000037902 enteropathy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000011640 ferrous citrate Substances 0.000 description 1
- 235000019850 ferrous citrate Nutrition 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000005027 intestinal barrier Anatomy 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000004673 intestinal mucosal barrier function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- APVZWAOKZPNDNR-UHFFFAOYSA-L iron(ii) citrate Chemical compound [Fe+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O APVZWAOKZPNDNR-UHFFFAOYSA-L 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000018648 unbalanced nutrition Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种溃疡性结肠炎专用型临床营养配方,其包括:蛋白质26‑35份、脂肪2‑8份、药食同源成分0.5~4份、新食品原料10‑40份、食品原料5‑25份、维生素A 0.0005‑0.0015份、维生素D 0.0001‑0.0003份、维生素E 0.025‑0.035份、维生素B10.001‑0.003份、维生素B20.001‑0.003份、维生素B60.001‑0.003份、维生素B120.000002‑0.000006份、维生素C 0.15‑0.25份、烟酸0.01‑0.03份、叶酸0.01‑0.03份、泛酸0.003‑0.008份、镁0.2‑0.4份、钙0.3‑0.8份、铁0.01‑0.02份、锌0.005‑0.015份;本发明还涉及上述临床营养配方的制备方法。本发明基于溃疡性结肠炎患者的营养摄入,通过选用合理的基础营养素,同时添加具有保护肠道功能和营养辅助支持的特殊营养素,以实现营养均衡,改善溃疡性结肠炎患者营养结构,辅助改善溃疡性结肠炎患者的肠道状态,改善其炎症反应及机体健康状况。
Description
技术领域
本发明涉及特殊医学用途配方食品领域,具体涉及一种溃疡性结肠炎专用型临床营养配方及其制备方法。
背景技术
炎症性肠病是一类与免疫相关且病因未明的肠道炎性疾病,包括溃疡性结肠炎、克罗恩病和病理学不能确定为溃疡性结肠炎或克罗恩病的未定型结肠炎。此类疾病有终生复发倾向。
溃疡性结肠炎是一种病因尚未明确的直肠和结肠慢性非特异性炎症性疾病、溃疡性疾病。病变主要限于大肠粘膜与粘膜下层。临床症状表现为腹泻、粘液脓便血、腹痛,且经常造成重要的营养素及液体流失。病情轻重不等,多呈反复发作的慢性病程。长期患病者结肠癌危险性高。
克罗恩病是一种病因尚不十分清楚的胃肠道慢性炎性肉芽肿性疾病。病变多见于末段回肠和邻近结肠,但从口腔至肝门各段消化道均可受累,呈节段性或跳跃式分布。临床上以腹痛、腹泻、腹块、瘘管形成和肠梗阻为特点,可伴有发热、营养障碍等全身表现以及关节、皮肤、眼、口腔黏膜、肝等肠外损害。有终生复发倾向,重症患者迁延不愈,预后不良。
近几十年来,炎症性肠病在亚洲和世界范围发病率有持续增高趋势。我国新近在南方(广州中山市)和北方(大庆市)地区流行病学研究显示:溃疡性结肠炎南北地区发病率接近,分别为3.14/10万和1.77/10万,而克罗恩病则南方明显高于北方,分别为1.09/10万和0.13/10万;总体溃疡性结肠炎的发病率高于克罗恩病,且轻中度溃疡性结肠炎比例高于欧美;炎症性肠病发病高峰年龄为15-25 岁,溃疡性结肠炎的发病平均年龄在48岁,亦可见于儿童或老年,男女发病率无明显差异。
炎症性结肠炎呈慢性病程,为终身复发性疾病,轻型及长期缓解者预后较好。重症且急性起病、有并发症及年龄>60岁者预后不良,但近年由于治疗水平提高,病死率已明显下降。慢性持续活动或反复发作频繁者,预后较差。病程漫长者癌变危险性增加。
胃肠道是人体进行正常消化、吸收与维持机体良好营养状态的中心器官。胃肠道疾病,尤其是炎症性肠病患者,极易发生营养不良。轻型患者可能没有或只有轻度铁缺乏,很少出现水与电解质紊乱;中、重型患者因铁丢失较多,可出现中度以上贫血;长期腹泻患者由于水、电解质、维生素、蛋白质等营养素从肠道大量丢失,患者可出现体重减轻、低蛋白血症、水与电解质紊乱、酸碱平衡失调,最终导致严重营养不良。
患有炎症性结肠炎的患者在营养方面具有以下不足:
1.营养素摄入减少:许多患者因病情主动或被动限值进食,导致能量和相关营养素摄入不足。
2.营养素吸收减少:炎症性肠病,尤其是克罗恩病患者,常并发小肠吸收不良症,其原因如下:(1)广泛小肠粘膜病变,或因病因而行小肠切除术后,导致小肠消化和吸收营养素面积减少。患者易发生脂肪泻,脂溶性维生素和矿物质缺乏;(2)克罗恩病患者伴有肠管狭窄或肠瘘时,可引起肠内容物积滞,小肠内细菌过度生长,导致肠道吸收不良。
3.营养素丢失过多:活动性炎症性肠病可见蛋白质大量丢失,导致低蛋白血症。消化道出血,可导致铁缺乏与贫血。而腹泻可造成钙、钾、镁、锌等矿物质大量丢失。
4.营养素需要量增加:炎症性肠病患者,当伴有脓肿等感染并发症时,机体对能量的需要量增加。
由于溃疡性结肠炎是一种病因尚未明确的直肠和结肠慢性非特异性炎症性疾病,现在给予的主要治疗方式是口服氨基水杨酸制剂,口服、灌肠或静脉注射糖皮质激素、免疫抑制剂和生物制剂。严重者采用手术治疗。但是长期使用药物容易产生依赖性,且会引发不良反应,且无法改善由于溃疡性结肠炎导致的机体营养不良的现象。
因此,开发一种适用于溃疡性结肠炎患者以改善其营养结构从而维持营养均衡的营养配方是十分必要的。
发明内容
本发明的目的在于克服现有技术中的缺陷,针对溃疡性结肠炎患者饮食结构不合理、营养不均衡等不良现状,提供一种溃疡性结肠炎专用型临床营养配方,该营养配方作为溃疡性结肠炎的肠内营养制剂,通过合理的膳食调配,搭配碳水化合物、蛋白质、脂肪的供给能量比值,选择多种维生素、矿物质、药食同源和新食品,减轻患者的临床症状,纠正水及电解质代谢紊乱,改善患者的营养状况。采用无渣或少渣、易消化的要素饮食,最大限度地减少粪便体积,减轻消化道负担。同时供给充足的能量、蛋白质、维生素和矿物质,适当限制脂肪和膳食纤维的摄入。
为实现上述目的,本发明采用如下技术方案:
本发明的第一个目的是提供一种溃疡性结肠炎专用型临床营养配方,其包括如下组分及其重量份数:蛋白质26-35份、脂肪2-8份、药食同源成分0.5~4份、新食品原料10-40份、食品原料5-25份、维生素A 0.0005-0.0015份、维生素D 0.0001-0.0003份、维生素E0.025-0.035份、维生素B1 0.001-0.003份、维生素 B2 0.001-0.003份、维生素B6 0.001-0.003份、维生素B12 0.000002-0.000006份、维生素C 0.15-0.25份、烟酸0.01-0.03份、叶酸0.01-0.03份、泛酸0.003-0.008 份、镁0.2-0.4份、钙0.3-0.8份、铁0.01-0.02份、锌0.005-0.015份。
为了进一步优化上述临床营养配方,本发明所采取的技术措施还包括:
进一步地,所述药食同源成分选自蒲公英、百合、薄荷、甘草、茯苓、覆盆子、木瓜、枸杞、黄精中的至少一种,更优选为蒲公英、木瓜;所述新食品原料包括圆苞车前子壳粉;所述食品原料包括发酵复合果蔬粉、牛蒡根粉、凤梨粉。
进一步地,所述营养配方还包括膳食纤维12~30份;所述膳食纤维来源于菊粉、聚葡萄糖、低聚半乳糖、低聚果糖、低聚木糖、低聚异麦芽糖、抗性糊精、燕麦β-葡聚糖中的至少一种。
进一步地,所述营养配方还包括碳水化合物25-38份;所述碳水化合物还来源于果糖、冰糖、乳糖、麦芽糊精、木薯淀粉、抗性淀粉中的至少一种;更优选为麦芽糊精、低聚果糖。
进一步地,所述蛋白质包括水解乳清蛋白粉、大豆分离蛋白、全蛋粉、白蛋白肽、大豆肽、大豆短肽、海洋鱼低聚肽、小麦低聚肽、玉米低聚肽粉、浓缩乳清蛋白粉、牛初乳粉、全脂奶粉、α-乳清蛋白粉、乳铁蛋白、L-谷氨酰胺中的至少一种。更优选为:水解乳清蛋白粉、大豆短肽、L-谷氨酰胺。
进一步地,所述脂肪包括鱼油微囊粉、亚麻籽油微囊粉、月见草油微囊粉、橄榄油微囊粉、链甘油三酯粉、二十二碳六烯酸油脂、花生四烯酸油脂、茶油微囊粉中的至少一种。更优选为:鱼油微囊粉、中链甘油三酯。
进一步地,所述钙来源于碳酸钙、葡萄糖酸钙、柠檬酸钙、乳酸钙、L-乳酸钙、磷酸氢钙、磷酸钙中的至少一种,更优选为L-乳酸钙。
进一步地,所述锌来源于葡萄糖酸锌、氧化锌、柠檬酸锌中的至少一种,更优选为葡萄糖酸锌。
进一步地,所述铁来源于葡萄糖酸亚铁、柠檬酸亚铁、柠檬酸铁、富马酸亚铁、乳酸亚铁、焦磷酸铁中的至少一种,更优选为葡萄糖酸亚铁。
进一步地,所述镁来源于硫酸镁、葡萄糖酸镁中的至少一种,更优选为葡萄糖酸镁。
进一步地,所述维生素C来源于L-抗坏血酸、L-抗坏血酸钠中的至少一种,更优选为L-抗坏血酸钠。
进一步地,所述维生素D来源于胆钙化醇、麦角钙化醇中的至少一种,更优选为胆钙化醇。
进一步地,所述维生素E来源于d-α-生育酚、dl-α-生育酚、d-α-醋酸生育酚、 dl-α-醋酸生育酚、d-α-琥珀酸生育酚、dl-α-琥珀酸生育酚中的至少一种,更优选为dl-α-醋酸生育酚。
进一步地,维生素B1来源于盐酸硫胺素、硝酸硫胺素中的至少一种,更优选为盐酸硫胺酸。
进一步地,维生素B2来源于核黄素。
进一步地,维生素B6来源于盐酸吡哆醇、5'-磷酸吡哆醛中的至少一种,更优选为盐酸吡哆醇。
进一步地,维生素B12来源于氰钴胺、盐酸氰钴胺中的一种或多种组合,更优选为氰钴胺。
进一步地,所述营养配方包括圆苞车前子壳粉、发酵复合果蔬粉、水解乳清蛋白粉、大豆短肽、鱼油微囊粉和中链甘油三酯中的至少一种、葡萄糖酸镁、L- 谷氨酰胺、牛蒡根粉、蒲公英粉、木瓜粉和凤梨粉中的至少一种、L-乳酸钙、硫酸镁、葡萄糖酸亚铁、葡萄糖酸锌、醋酸视黄酯、胆钙化醇、dl-α-醋酸生育酚、盐酸硫氨酸、核黄素、盐酸吡哆醇、氰钴胺、L-抗坏血酸钠、D-泛酸钙、烟酰胺、叶酸。更进一步地,所述营养配方还包括麦芽糊精、低聚果糖。
本发明的第二个目的是提供一种上述溃疡性结肠炎专用型临床营养配方的制备方法方法,其包括如下步骤:称取预定量的各原料,其中维生素、微量元素和常量元素、药食同源成分和新食品原料预先制备成预混料;将预混料和2%麦芽糊精先混合5~15分钟;将其它原料按照逐级递增的原则加入进行混合,混合 10~30分钟,出料,分装。
进一步地,上述各原料均为粒径为50~200μm的粉末形式的原料,配置前及配置完成后均经过杀菌处理。
进一步地,所述营养配方的剂型包括营养粉、营养乳剂、胶囊剂、片剂、丸剂、口服液等。
与现有技术相比,本发明具有以下有益效果:
因炎症性肠病患者的蛋白质需求增加,本发明营养配方补充丰富的高生物价优质蛋白质,优质蛋白质有益于人体消化吸收系统的吸收利用,全面均衡地补充人体所需的8种必须氨基酸,防止出现负氮平衡,提高免疫力。
克洛恩病患者、回肠疾病或回肠切除手术者,往往发生脂肪泻。未被吸收的脂肪酸,以及肠道细菌产生的羟基脂肪酸衍生物,均可刺激肠道而加重腹泻症状。而本发明制备的营养配方采用低脂肪膳食,以减轻肠道负担,其所含的n-3不饱和脂肪酸抑制炎症细胞因子的表达,减轻肠粘膜损伤。
溃疡性结肠炎患者易发生肠腔狭窄、肠梗阻或腹泻,本发明所述的营养配方适度减少膳食纤维的摄入量,采用无渣或低渣饮食。所添加的适量的膳食纤维能减轻肠道负担,促进双歧杆菌增殖和生长。
本发明所述的营养配方及时予以补充溃疡性结肠炎患者因严重腹泻脱水而造成大量丢失的矿物质(钾、钠、镁、钙、铁、锌)和维生素(维生素A、维生素D、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、泛酸)。本发明营养配方中适度添加钙,钙是构成骨骼的重要成分,而骨病是炎症性结肠炎患者常见的并发症,主要由于钙及维生素D吸收不良,合理补充钙及维生素D能有效预防骨质减少和骨质疏松;适度添加维生素D,维生素D除参与钙、磷代谢外,还可通过调节机体免疫细胞因子,诱导表达抗菌肽以及维持肠粘膜屏障的完整性,缓解炎症性肠病的疾病程度;适度添加锌,锌是人体正常免疫系统和控制炎症过程不可缺少的物质,辅助缓解肠道炎症反应症状;适度添加维生素B12,其作为同型半胱氨酸合成甲硫氨酸的辅酶,叶酸作为甲基供体,在半胱氨酸代谢过程中起着重要作用,维生素B12的缺乏可引起高同型半胱氨酸血症,进而引起肠粘膜上皮的炎症状态。
且本发明所述的营养配方同时配伍药食同源成分,其含有天然生物活性因子,有效保护肠道功能,并添加新食品原料和食品原料,辅助炎症性结肠炎患者的营养支持。
本发明通过选用合理的基础营养素,基于溃疡性结肠炎患者的营养摄入,对各组分的配比进行适应性调整,同时添加具有保护肠道功能和营养辅助支持的特殊营养素,以实现营养均衡,改善溃疡性结肠炎患者营养结构,辅助改善溃疡性结肠炎患者的肠道状态,改善其炎症反应及机体健康状况。
具体实施方式
本发明提供一种溃疡性结肠炎专用型临床营养配方,其包括如下组分及其重量份数:蛋白质26-35份、脂肪2-8份、药食同源成分0.5~4份、新食品原料10-40 份、食品原料5-25份、维生素A 0.0005-0.0015份、维生素D 0.0001-0.0003份、维生素E 0.025-0.035份、维生素B1 0.001-0.003份、维生素B2 0.001-0.003份、维生素B6 0.001-0.003份、维生素B120.000002-0.000006份、维生素C 0.15-0.25 份、烟酸0.01-0.03份、叶酸0.01-0.03份、泛酸0.003-0.008份、镁0.2-0.4份、钙0.3-0.8份、铁0.01-0.02份、锌0.005-0.015份。
下面结合实施例,对本发明的具体实施方式作进一步描述。以下实施例仅用于更加清楚地说明本发明的技术方案,而不能以此来限制本发明的保护范围。
实施例1
本发明所述的溃疡性结肠炎专用型临床营养配方每100g包括以下组分:
制备方法:按照组分表称量各组分,其中维生素、矿物质、药食同源和新食品原料按照表格先制备成制备预混料;将复合维生素、复合矿物质、药食同源、新食品原料和2%水解乳清蛋白粉先混合10分钟;然后将其它物料按照逐级递增的原则投入混合机,混合20分钟,出料,称重记录,分装。
实施例2
本发明所述的溃疡性结肠炎专用型临床营养配方每100g包括以下组分:
组分 | 重量(g) |
水解乳清蛋白粉 | 30 |
麦芽糊精 | 26.177996 |
圆苞车前子壳粉 | 12 |
发酵复合果蔬粉 | 6 |
大豆短肽 | 5 |
鱼油微囊粉 | 5 |
低聚果糖 | 3 |
中链甘油三酯 | 3 |
葡萄糖酸镁 | 3 |
L-谷氨酰胺 | 2 |
牛蒡根粉 | 1 |
蒲公英粉 | 1 |
凤梨粉 | 1 |
L-乳酸钙 | 0.5 |
硫酸镁 | 0.02 |
葡萄糖酸亚铁 | 0.01 |
葡萄糖酸锌 | 0.01 |
醋酸视黄酯 | 0.001 |
胆钙化醇 | 0.0001 |
dl-α-醋酸生育酚 | 0.03 |
盐酸硫氨酸 | 0.002 |
核黄素 | 0.002 |
盐酸吡哆醇 | 0.002 |
氰钴胺 | 0.000004 |
L-抗坏血酸钠 | 0.20 |
D-泛酸钙 | 0.005 |
烟酰胺 | 0.02 |
叶酸 | 0.02 |
制备方法:按照组分表称量各组分,其中维生素、矿物质、药食同源和新食品原料按照表格先制备成制备预混料;将复合维生素、复合矿物质、药食同源、新食品原料和2%麦芽糊精先混合10分钟;然后将其它物料按照逐级递增的原则投入混合机,混合20分钟,出料,称重记录,分装。
实施例3
本发明所述的溃疡性结肠炎专用型临床营养配方每100g包括以下组分:
制备方法:按照组分表称量各组分,其中维生素、矿物质、药食同源和新食品原料按照表格先制备成制备预混料;将复合维生素、复合矿物质、药食同源、新食品原料和2%麦芽糊精先混合10分钟;然后将其它物料按照逐级递增的原则投入混合机,混合20分钟,出料,称重记录,分装。
应用实施例
本实施例采用实施例1制备的营养粉的抗溃疡性结肠炎性能进行验证。
试验方法:昆明种雄性小鼠40只,饲养一周,随机分4组:空白组,UC 模型组,美沙拉嗪组,营养配方组,空白组小鼠饮用纯净水,其他小鼠自饮5% DSS 7天诱导UC模型。确定小鼠造模成功后,将小鼠按照下述方式治疗15天,空白组和UC模型组灌胃5%生理盐水,1mL/天;美沙拉嗪组灌胃125mg/kg的美沙拉嗪混悬液,1ml/天;营养配方组灌胃0.15g/ml的粉剂溶液,均1.2ml/天。
在治疗期间对小鼠的大便性状及大便隐血情况进行观察记录,其结果为:美沙拉嗪组和营养配方组的小鼠体重均无明显下降,且其大便性状均从稀便和松散大便变为正常大便,且其隐血情况日益改善,空白组从始至终大便性状均为正常且无隐血,而模型组的小鼠体重具有下降趋势,且大便性状和隐血情况日益加重。
由上可知,本发明所制备的营养配方能够有效地缓解炎症性肠病的疾病程度,并在一定程度上辅助治疗溃疡性结肠炎。
以上对本发明的具体实施例进行了详细描述,但其只作为范例,本发明并不限制于以上描述的具体实施例。对于本领域技术人员而言,任何对本发明进行的等同修改和替代也都在本发明的范畴之中。因此,在不脱离本发明的精神和范围下所作的均等变换和修改,都应涵盖在本发明的范围内。
Claims (10)
1.一种溃疡性结肠炎专用型临床营养配方,其特征在于,包括如下组分及其重量份数:蛋白质26-35份、脂肪2-8份、药食同源成分0.5~4份、新食品原料10-40份、食品原料5-25份、维生素A 0.0005-0.0015份、维生素D 0.0001-0.0003份、维生素E 0.025-0.035份、维生素B1 0.001-0.003份、维生素B2 0.001-0.003份、维生素B6 0.001-0.003份、维生素B120.000002-0.000006份、维生素C 0.15-0.25份、烟酸0.01-0.03份、叶酸0.01-0.03份、泛酸0.003-0.008份、镁0.2-0.4份、钙0.3-0.8份、铁0.01-0.02份、锌0.005-0.015份。
2.根据权利要求1所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述药食同源成分选自蒲公英、百合、薄荷、甘草、茯苓、覆盆子、木瓜、枸杞、黄精中的至少一种,所述新食品原料包括圆苞车前子壳粉,所述食品原料包括发酵复合果蔬粉、牛蒡根粉、凤梨粉。
3.根据权利要求1所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述营养配方还包括膳食纤维12~30份;所述膳食纤维来源于菊粉、聚葡萄糖、低聚半乳糖、低聚果糖、低聚木糖、低聚异麦芽糖、抗性糊精、燕麦β-葡聚糖中的至少一种。
4.根据权利要求1所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述营养配方还包括碳水化合物25-38份;所述碳水化合物还来源于果糖、冰糖、乳糖、麦芽糊精、木薯淀粉、抗性淀粉中的至少一种。
5.根据权利要求1所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述蛋白质包括水解乳清蛋白粉、大豆分离蛋白、全蛋粉、白蛋白肽、大豆肽、大豆短肽、海洋鱼低聚肽、小麦低聚肽、玉米低聚肽粉、浓缩乳清蛋白粉、牛初乳粉、全脂奶粉、α-乳清蛋白粉、乳铁蛋白、L-谷氨酰胺中的至少一种。
6.根据权利要求1所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述脂肪包括鱼油微囊粉、亚麻籽油微囊粉、月见草油微囊粉、橄榄油微囊粉、链甘油三酯粉、二十二碳六烯酸油脂、花生四烯酸油脂、茶油微囊粉中的至少一种。
7.根据权利要求1所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述钙来源于碳酸钙、葡萄糖酸钙、柠檬酸钙、乳酸钙、L-乳酸钙、磷酸氢钙、磷酸钙中的至少一种;所述锌来源于葡萄糖酸锌、氧化锌、柠檬酸锌中的至少一种;所述维生素C来源于L-抗坏血酸、L-抗坏血酸钠中的至少一种;所述维生素D来源于胆钙化醇、麦角钙化醇中的至少一种,所述维生素E来源于d-α-生育酚、dl-α-生育酚、d-α-醋酸生育酚、dl-α-醋酸生育酚、d-α-琥珀酸生育酚、dl-α-琥珀酸生育酚中的至少一种。
8.根据权利要求1所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述营养配方包括圆苞车前子壳粉、发酵复合果蔬粉、水解乳清蛋白粉、大豆短肽、鱼油微囊粉和中链甘油三酯中的至少一种、葡萄糖酸镁、L-谷氨酰胺、牛蒡根粉、蒲公英粉、木瓜粉和凤梨粉中的至少一种、L-乳酸钙、硫酸镁、葡萄糖酸亚铁、葡萄糖酸锌、醋酸视黄酯、胆钙化醇、dl-α-醋酸生育酚、盐酸硫氨酸、核黄素、盐酸吡哆醇、氰钴胺、L-抗坏血酸钠、D-泛酸钙、烟酰胺、叶酸。
9.根据权利要求8所述的一种溃疡性结肠炎专用型临床营养配方,其特征在于,所述营养配方还包括麦芽糊精、低聚果糖。
10.一种如权利要求1~9中任一项所述的溃疡性结肠炎专用型临床营养配方的制备方法,其特征在于,包括如下步骤:称取预定量的各原料,其中维生素、微量元素和常量元素、药食同源成分和新食品原料预先制备成预混料;将预混料和2%麦芽糊精先混合5~15分钟;将其它原料按照逐级递增的原则加入进行混合,混合10~30分钟,出料,分装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910539305.2A CN110226741A (zh) | 2019-06-20 | 2019-06-20 | 一种溃疡性结肠炎专用型临床营养配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910539305.2A CN110226741A (zh) | 2019-06-20 | 2019-06-20 | 一种溃疡性结肠炎专用型临床营养配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110226741A true CN110226741A (zh) | 2019-09-13 |
Family
ID=67856999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910539305.2A Withdrawn CN110226741A (zh) | 2019-06-20 | 2019-06-20 | 一种溃疡性结肠炎专用型临床营养配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110226741A (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110638042A (zh) * | 2019-11-04 | 2020-01-03 | 光明乳业股份有限公司 | 一种全营养配方食品及其应用 |
CN111493326A (zh) * | 2020-04-28 | 2020-08-07 | 成都尚医信息科技有限公司 | 一种肠内营养食品及其制备方法和应用 |
CN111513332A (zh) * | 2020-05-31 | 2020-08-11 | 上海复旦奥医医学科技有限公司 | 大肠癌专用型临床营养配方及其制备方法 |
CN111513333A (zh) * | 2020-05-31 | 2020-08-11 | 上海复旦奥医医学科技有限公司 | 肺癌专用型临床营养配方食品及其制备方法 |
CN111713691A (zh) * | 2020-06-26 | 2020-09-29 | 上海复旦奥医医学科技有限公司 | 一种用于治疗慢性胃炎的临床营养配方食品及其制备方法 |
CN113615831A (zh) * | 2021-08-31 | 2021-11-09 | 西安交通大学医学院第一附属医院 | 一种促进溃疡性结肠炎粘膜修复的临床营养组合物及其制备方法 |
CN114015737A (zh) * | 2021-11-29 | 2022-02-08 | 齐齐哈尔大学 | 一种具有肠道屏障保护功能的玉米谷氨酰胺肽的制备方法和应用 |
CN114982970A (zh) * | 2022-01-29 | 2022-09-02 | 石药集团中诺药业(泰州)有限公司 | 一种辅助治疗内腔粘膜炎的抗炎营养素含片及其制备方法 |
CN115697084A (zh) * | 2020-04-01 | 2023-02-03 | 沃尔夫森医疗中心 | 溃疡性结肠炎膳食、配方、产品及其方法 |
CN116849354A (zh) * | 2023-04-21 | 2023-10-10 | 兰州大学 | 一种添加植物乳杆菌gl-5的炎症性肠病全营养配方食品 |
-
2019
- 2019-06-20 CN CN201910539305.2A patent/CN110226741A/zh not_active Withdrawn
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110638042A (zh) * | 2019-11-04 | 2020-01-03 | 光明乳业股份有限公司 | 一种全营养配方食品及其应用 |
CN115697084A (zh) * | 2020-04-01 | 2023-02-03 | 沃尔夫森医疗中心 | 溃疡性结肠炎膳食、配方、产品及其方法 |
CN111493326A (zh) * | 2020-04-28 | 2020-08-07 | 成都尚医信息科技有限公司 | 一种肠内营养食品及其制备方法和应用 |
CN111513332A (zh) * | 2020-05-31 | 2020-08-11 | 上海复旦奥医医学科技有限公司 | 大肠癌专用型临床营养配方及其制备方法 |
CN111513333A (zh) * | 2020-05-31 | 2020-08-11 | 上海复旦奥医医学科技有限公司 | 肺癌专用型临床营养配方食品及其制备方法 |
CN111713691A (zh) * | 2020-06-26 | 2020-09-29 | 上海复旦奥医医学科技有限公司 | 一种用于治疗慢性胃炎的临床营养配方食品及其制备方法 |
CN113615831B (zh) * | 2021-08-31 | 2023-09-01 | 西安交通大学医学院第一附属医院 | 一种促进溃疡性结肠炎粘膜修复的临床营养组合物及其制备方法 |
CN113615831A (zh) * | 2021-08-31 | 2021-11-09 | 西安交通大学医学院第一附属医院 | 一种促进溃疡性结肠炎粘膜修复的临床营养组合物及其制备方法 |
CN114015737A (zh) * | 2021-11-29 | 2022-02-08 | 齐齐哈尔大学 | 一种具有肠道屏障保护功能的玉米谷氨酰胺肽的制备方法和应用 |
CN114015737B (zh) * | 2021-11-29 | 2023-09-29 | 齐齐哈尔大学 | 一种具有肠道屏障保护功能的玉米谷氨酰胺肽的制备方法和应用 |
CN114982970A (zh) * | 2022-01-29 | 2022-09-02 | 石药集团中诺药业(泰州)有限公司 | 一种辅助治疗内腔粘膜炎的抗炎营养素含片及其制备方法 |
CN114982970B (zh) * | 2022-01-29 | 2024-02-09 | 石药集团中诺药业(泰州)有限公司 | 一种辅助保护内腔粘膜的营养素含片及其制备方法 |
CN116849354A (zh) * | 2023-04-21 | 2023-10-10 | 兰州大学 | 一种添加植物乳杆菌gl-5的炎症性肠病全营养配方食品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110226741A (zh) | 一种溃疡性结肠炎专用型临床营养配方及其制备方法 | |
ES2886951T3 (es) | Composición para su uso en la modulación de la microbiota | |
CN101061860B (zh) | 富含亮氨酸的营养组合物 | |
CN106983151A (zh) | 一种炎性肠病专用型临床营养配方及其制备方法 | |
CN106983136A (zh) | 一种产褥期调理专用型临床营养配方及其制备方法 | |
CN105029407A (zh) | 炎性肠病医学配方食品 | |
WO2007061959A2 (en) | High quality caloric composition | |
JP2011513458A (ja) | 中鎖ジカルボン酸、その誘導体及び代謝異常 | |
CN110720628A (zh) | 一种保护化疗损伤肠黏膜屏障功能专用型临床营养配方及其制备方法 | |
CN110226744A (zh) | 一种前列腺炎专用型临床营养配方及其制备方法 | |
CN108294231A (zh) | 适合糖尿病患者食用的营养主食 | |
CN109169916A (zh) | 一种产妇营养品及其生产工艺 | |
CN105410932A (zh) | 一种肿瘤免疫型营养组合物及其应用 | |
CN110742267B (zh) | 一种炎性肠病全营养配方食品 | |
JP2023503401A (ja) | 妊婦の細菌叢を改善するためのhmoの混合物 | |
CN110754656A (zh) | 一种淋巴肿瘤功能专用型临床营养配方及其制备方法 | |
CN104839695A (zh) | 炎性肠病非全营养配方食品 | |
CN110214942A (zh) | 一种甲亢专用型医学营养配方及其制备方法 | |
CN107467193B (zh) | 一种以羊奶为基础的粉剂全营养特殊医学用途配方食品及其制备方法 | |
CN107960656A (zh) | 一种孕妇产前营养组合物 | |
CN109156530A (zh) | 一种辅食营养包及其生产工艺 | |
Barretto et al. | Use of dietary supplements by children and adolescents | |
CN110547472A (zh) | 一种含肽类特殊医学用途配方食品及其制备方法 | |
CN113598363A (zh) | 一种用于癌因性疲乏的特殊医学用途全营养配方食品 | |
CN104839642A (zh) | 卵巢癌医学配方食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190913 |
|
WW01 | Invention patent application withdrawn after publication |